Actinic Keratosis Clinical Trials

8 recruiting

Actinic Keratosis Trials at a Glance

9 actively recruiting trials for actinic keratosis are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 1 with 3 trials, with the heaviest enrollment activity in New Brighton, Nashville, and Aventura. Lead sponsors running actinic keratosis studies include Sun Pharmaceutical Industries, Inc., Hubei Bio-Pharmaceutical Industrial Technological Institute Inc., and Cosmetique Active International.

Browse actinic keratosis trials by phase

Treatments under study

About Actinic Keratosis Clinical Trials

Looking for clinical trials for Actinic Keratosis? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Actinic Keratosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Actinic Keratosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 3

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities

Actinic Keratosis
Sun Pharmaceutical Industries, Inc.260 enrolled20 locationsNCT07144852
Recruiting
Phase 3

Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp

Actinic Keratosis
Sun Pharmaceutical Industries, Inc.160 enrolled10 locationsNCT07144345
Recruiting
Phase 1Phase 2

Evaluate RLS-1496 Topical Cream for Actinic Keratosis

Actinic Keratosis (AK)
Rubedo Life Sciences, Inc.24 enrolled4 locationsNCT07340697
Recruiting
Not Applicable

Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses

Actinic Keratosis (AK)
Cosmetique Active International80 enrolled1 locationNCT07335003
Recruiting
Phase 1

A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis.

Actinic Keratosis (AK)
Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.40 enrolled1 locationNCT07318675
Recruiting
Phase 2

The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans

Photodynamic TherapyActinic KeratosisImipramine
VA Office of Research and Development48 enrolled1 locationNCT06778434
Recruiting
Phase 3

Phase 3 - Evaluation of Veregen® 10% Ointment as New Herbal Topical Treatment for Actinic Keratosis

Actinic Keratosis of Face and Scalp
Aresus Pharma GmbH280 enrolled1 locationNCT07137819
Recruiting

Investigation of the Efficacy and Tolerability of Topical Applied Tirbanibulin on Actinic Keratoses With Downward-directed Proliferation Patterns

Actinic Keratosis (AK)
Thomas Dirschka20 enrolled1 locationNCT06648447
Recruiting
Phase 1

The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy

Photodynamic TherapyActinic KeratosisImipramine
Wright State University24 enrolled1 locationNCT05688904